They have a profit making subsidiary that is forecasting $4.2m in revenues in 2020 and also have patents for MPL in the treatment of Alzheimer's, Parkinson's and other degenerative diseases.
Pharmaust Phase II K9 Trial, page-171
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $87.55M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 18.0¢ | $19.81K | 110.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 200401 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 302275 | 5 |
View Market Depth
| Last trade - 10.44am 13/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |